A Phase III clinical trial including patients at the University of Oklahoma found that proton therapy improved survival and resulted in fewer side effects among people with head and neck cancer. The ...
The FDA's Fast Track designation helps to accelerate the development and review of products for serious and life-threatening conditions.
Ten percent higher 5-year overall survival rates in patients receiving precise proton therapy vs. traditional radiation therapy Patients had significantly fewer side effects and improved quality of ...
Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with resectable locally advanced head and neck squamous ...
Second opinions on cancer treatment plans can save thousands of dollars in health care costs.A retrospective analysis showed ...
Head and neck (NH) cancers can develop in several distinct locations including the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx. A known side effect of head and neck (HN) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results